We have also demonstrated that MTA1 is a molecular target for stilbene polyphenols, such as resveratrol, pterostilbene, and gnetin C, in prostate cancer, in vitro and in vivo [22,24,25,26,34,35,40,41]. The gene discussed is MTA1; the disease is prostate carcinoma.